Skip to main content
SpringerLink
Log in

The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

A disintegrin and metalloprotease with thrombospondin domains (ADAMTS)-4 (aggrecanase-1) and ADAMTS-5 (aggrecanase-2) are metalloproteases involved in articular cartilage degradation and represent potential therapeutic targets in arthritis treatment. We explore herein the ability of different natural compounds to specifically block the destructive action of these enzymes. Following a preliminary screening using carboxymethylated transferrin as substrate, we focused our interest on luteolin due to its inhibitory effect on ADAMTS-4 and ADAMTS-5 activities using aggrecan and fluorogenic peptides as substrates. However, matrix metalloproteinases (MMPs) activities on these substrates result less affected by this flavonoid. Moreover, incubation of mouse chondrogenic ATDC5 cells in the presence of luteolin clearly decreases the release of aggrecan fragments mediated by aggrecanases under the same conditions in which aggrecanolysis mediated by MMPs is detected. Additionally, glycosaminoglycan levels in culture medium of murine cartilage explants stimulated with interleukin-1-alpha plus retinoic acid are reduced by the presence of the flavonoid. This inhibition takes place through blockade of ADAMTS-mediated aggrecanolysis, while MMPs activity is not or poorly affected. These results suggest that luteolin could be employed as a prototypic modifying disease-agent to create new chondroprotective compounds aimed to specifically block the unwanted aggrecanase activities in arthritic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Nagase H, Kashiwagi M (2003) Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 5:94–103

    Article  PubMed  CAS  Google Scholar 

  2. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678–685

    Article  PubMed  CAS  Google Scholar 

  3. Arner EC (2002) Aggrecanase-mediated cartilage degradation. Curr Opin Pharmacol 2:322–329

    Article  PubMed  CAS  Google Scholar 

  4. Sandy JD (2006) A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage 14:95–100

    Article  PubMed  CAS  Google Scholar 

  5. Fosang AJ, Little CB (2008) Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Nat Clin Pract Rheumatol 4:420–427

    Article  PubMed  CAS  Google Scholar 

  6. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, Tryggvason K (2000) Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 97:4052–4057

    Article  PubMed  CAS  Google Scholar 

  7. Colnot C, Thompson Z, Miclau T, Werb Z, Helms JA (2003) Altered fracture repair in the absence of MMP9. Development 130:4123–4133

    Article  PubMed  CAS  Google Scholar 

  8. Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, Little CB, Last K, Farmer PJ, Campbell IK et al (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434:648–652

    Article  PubMed  CAS  Google Scholar 

  9. Colic M, Pavelic K (2000) Molecular mechanisms of anticancer activity of natural dietetic products. J Mol Med 78:333–336

    Article  PubMed  CAS  Google Scholar 

  10. Vankemmelbeke MN, Jones GC, Fowles C, Ilic MZ, Handley CJ, Day AJ, Knight CG, Mort JS, Buttle DJ (2003) Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters. Eur J Biochem 270:2394–2403

    Article  PubMed  CAS  Google Scholar 

  11. Imada K, Lin N, Liu C, Lu A, Chen W, Yano M, Sato T, Ito A (2008) Nobiletin, a citrus polymethoxy flavonoid, suppresses gene expression and production of aggrecanases-1 and -2 in collagen-induced arthritic mice. Biochem Biophys Res Commun 373:181–185

    Article  PubMed  CAS  Google Scholar 

  12. Lopez-Lazaro M (2009) Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 9:31–59

    Article  PubMed  CAS  Google Scholar 

  13. Jang S, Kelley KW, Johnson RW (2008) Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci USA 105:7534–7539

    Article  PubMed  CAS  Google Scholar 

  14. Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C (2001) Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 296:181–187

    PubMed  CAS  Google Scholar 

  15. Nagase H (1995) Human stromelysins 1 and 2. Meth Enzymol 248:449–470

    Article  PubMed  CAS  Google Scholar 

  16. Gendron C, Kashiwagi M, Lim NH, Enghild JJ, Thogersen IB, Hughes C, Caterson B, Nagase H (2007) Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem 282:18294–18306

    Article  PubMed  CAS  Google Scholar 

  17. Otero M, Gomez Reino JJ, Gualillo O (2003) Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 48:404–409

    Article  PubMed  CAS  Google Scholar 

  18. Arner EC, Pratta MA, Trzaskos JM, Decicco CP, Tortorella MD (1999) Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity. J Biol Chem 274:6594–6601

    Article  PubMed  CAS  Google Scholar 

  19. Majumdar MK, Askew R, Schelling S, Stedman N, Blanchet T, Hopkins B, Morris EA, Glasson SS (2007) Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum 56:3670–3674

    Article  PubMed  CAS  Google Scholar 

  20. Barbosa I, Garcia S, Barbier-Chassefiere V, Caruelle JP, Martelly I, Papy-Garcia D (2003) Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 13:647–653

    Article  PubMed  CAS  Google Scholar 

  21. Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara AB, Sung B, Aggarwal A, Aggarwal BB (2007) Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 7:344–351

    Article  PubMed  CAS  Google Scholar 

  22. Sandy JD, Neame PJ, Boynton RE, Flannery CR (1991) Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem 266:8683–8685

    PubMed  CAS  Google Scholar 

  23. Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657–672

    Article  PubMed  CAS  Google Scholar 

  24. Lopez-Otin C, Palavalli LH, Samuels Y (2009) Protective roles of matrix metalloproteinases: from mouse models to human cancer. Cell Cycle 8:3657–3662

    Article  PubMed  CAS  Google Scholar 

  25. Lopez-Otin C, Matrisian LM (2007) Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7:800–808

    Article  PubMed  CAS  Google Scholar 

  26. Moncada-Pazos A, Obaya AJ, Fraga MF, Viloria CG, Capella G, Gausachs M, Esteller M, Lopez-Otin C, Cal S (2009) The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci 122:2906–2913

    Article  PubMed  CAS  Google Scholar 

  27. Viloria CG, Obaya AJ, Moncada-Pazos A, Llamazares M, Astudillo A, Capella G, Cal S, Lopez-Otin C (2009) Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer. Cancer Res 69:4926–4934

    Article  PubMed  CAS  Google Scholar 

  28. Nagase H, Fushimi K (2008) Elucidating the function of non catalytic domains of collagenases and aggrecanases. Connect Tissue Res 49:169–174

    Article  PubMed  CAS  Google Scholar 

  29. Troeberg L, Fushimi K, Khokha R, Emonard H, Ghosh P, Nagase H (2008) Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J 22:3515–3524

    Article  PubMed  CAS  Google Scholar 

  30. Patwari P, Kurz B, Sandy JD, Grodzinsky AJ (2000) Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage. Arch Biochem Biophys 374:79–85

    Article  PubMed  CAS  Google Scholar 

  31. Kim JK, Shin EK, Park JH, Kim YH (2010) Antitumor and antimetastatic effects of licochalcone A in mouse models. J Mol Med 88:829–838

    Article  PubMed  CAS  Google Scholar 

  32. Lauer-Fields JL, Spicer TP, Chase PS, Cudic M, Burstein GD, Nagase H, Hodder P, Fields GB (2008) Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate. Anal Biochem 373:43–51

    Article  PubMed  CAS  Google Scholar 

  33. Ende C, Gebhardt R (2004) Inhibition of matrix metalloproteinase-2 and -9 activities by selected flavonoids. Planta Med 70:1006–1008

    Article  PubMed  CAS  Google Scholar 

  34. Hou Y, Wu J, Huang Q, Guo L (2009) Luteolin inhibits proliferation and affects the function of stimulated rat synovial fibroblasts. Cell Biol Int 33:135–147

    Article  PubMed  CAS  Google Scholar 

  35. Cudic M, Burstein GD, Fields GB, Lauer-Fields J (2009) Analysis of flavonoid-based pharmacophores that inhibit aggrecanases (ADAMTS-4 and ADAMTS-5) and matrix metalloproteinases through the use of topologically constrained peptide substrates. Chem Biol Drug Des 74:473–482

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Sonsoles Alvarez for her excellent technical support. This work was supported by grants from Ministerio de Ciencia e Innovación-Spain, Fundación M. Botín and European Union (FP7-MicroEnviMet); The Instituto Universitario de Oncología is supported by Obra Social Cajastur.

Disclosure

The authors declare no conflict of interest related to this study.

Author information

Authors and Affiliations

  1. Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología ,Universidad de Oviedo, 33006, Oviedo, Spain

    Angela Moncada-Pazos, Cristina G. Viloria, Carlos López-Otín & Santiago Cal

  2. Departamento de Biología Funcional, Instituto Universitario de Oncología, Universidad de Oviedo, 33006, Oviedo, Spain

    Alvaro J. Obaya

  3. Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo. c/ Fernando Bongera s/n, 33006, Oviedo, Spain

    Santiago Cal

Authors
  1. Angela Moncada-Pazos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alvaro J. Obaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cristina G. Viloria
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlos López-Otín
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Santiago Cal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Santiago Cal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moncada-Pazos, A., Obaya, A.J., Viloria, C.G. et al. The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities. J Mol Med 89, 611–619 (2011). https://doi.org/10.1007/s00109-011-0741-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-011-0741-7

Keywords

Search

Navigation